Osaic Holdings’s enVVeno Medical NVNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70 Hold
7
﹤0.01% 7657
2025
Q4
$80 Hold
7
﹤0.01% 7664
2025
Q3
$232 Hold
7
﹤0.01% 7678
2025
Q2
$997 Hold
7
﹤0.01% 7146
2025
Q1
$657 Sell
7
-10
-59% -$1.11K ﹤0.01% 6930
2024
Q4
$1.81K Hold
17
﹤0.01% 6646
2024
Q3
$2.02K Hold
17
﹤0.01% 6611
2024
Q2
$3.15K Sell
17
-307
-95% -$53.6K ﹤0.01% 6404
2024
Q1
$61.7K Hold
324
﹤0.01% 4589
2023
Q4
$58.3K Hold
324
﹤0.01% 4808
2023
Q3
$61.2K Sell
324
-2
-0.6% -$334 ﹤0.01% 4850
2023
Q2
$35.2K Hold
326
﹤0.01% 5177
2023
Q1
$53.5K Hold
326
﹤0.01% 4900
2022
Q4
$58K Hold
326
﹤0.01% 4821
2022
Q3
$72K Sell
326
-5
-2% -$1.06K ﹤0.01% 4629
2022
Q2
$44K Buy
331
+308
+1,339% +$47.8K ﹤0.01% 5056
2022
Q1
$5K Sell
23
-87
-79% -$16.9K ﹤0.01% 6490
2021
Q4
$25K Hold
110
﹤0.01% 5642
2021
Q3
$40K Sell
110
-2
-2% -$518 ﹤0.01% 5272
2021
Q2
$26K Sell
112
-27
-19% -$5.8K ﹤0.01% 5496
2021
Q1
$32K Buy
139
+122
+718% +$34K ﹤0.01% 5191
2020
Q4
$5K Hold
17
﹤0.01% 5782
2020
Q3
$6K Hold
17
﹤0.01% 5513
2020
Q2
$6K Hold
17
﹤0.01% 5409
2020
Q1
$4K Buy
+17
New +$8.07K ﹤0.01% 5450

Other funds holding NVNO

Osaic Holdings's NVNO Position: Q1 2026 in Review

Osaic Holdings held its enVVeno Medical (NVNO) position steady in Q1 2026 at 7 shares worth $70. The position accounts for ﹤0.01% of the portfolio, ranked #7657.

Osaic Holdings first reported a position in NVNO in Q1 2020 and has held it in 25 quarters since. The position peaked at $72K in Q3 2022. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Osaic Holdings held 7 shares of enVVeno Medical worth $70 as of Q1 2026.
  • Osaic Holdings left its enVVeno Medical share count unchanged in Q1 2026.
  • enVVeno Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7657 holding.
  • Osaic Holdings first reported a position in enVVeno Medical in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's enVVeno Medical position peaked at $72K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.